THE EFFECT OF ANTI-PD-1 THERAPY ON MEDIAN OVERALL SURVIVAL AND PROGRESSION FREE SURVIVAL IN GLIOBLASTOMA MULTIFORME PATIENTS WITH CERTAIN TUMOR MARKERS

被引：1
|
作者：
Paracha, Awais [1 ]
Campian, Jian [2 ]
机构：
[1] St Louis Univ, Sch Med, St Louis, MO USA
[2] Washington Univ, St Louis, MO 63110 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
关键词：
D O I：
10.1136/jitc-2020-SITC2020.0214
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
214
引用
收藏
页码：A128 / A128
页数：1
相关论文
共 50 条
  • [31] Anti-PD-1 Therapy is Beneficial for the Survival of Patients with Oral Squamous Cell Carcinoma
    Feng, Liang
    Yin, Ke
    Zhang, Suxin
    Chen, Zhong
    Bao, Yang
    Li, Tianke
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2723 - 2731
  • [32] Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis
    Harshit Arora
    Marco Mammi
    Naisargi Manishkumar Patel
    Dea Zyfi
    Hema Reddy Dasari
    Ismael Yunusa
    Thomas Simjian
    Timothy R. Smith
    Rania A. Mekary
    Journal of Neuro-Oncology, 2024, 166 : 17 - 26
  • [33] Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis
    Arora, Harshit
    Mammi, Marco
    Patel, Naisargi Manishkumar
    Zyfi, Dea
    Dasari, Hema Reddy
    Yunusa, Ismael
    Simjian, Thomas
    Smith, Timothy R.
    Mekary, Rania A.
    JOURNAL OF NEURO-ONCOLOGY, 2024, 166 (01) : 17 - 26
  • [34] A New Signature That Predicts Progression-Free Survival of Clear Cell Renal Cell Carcinoma with Anti-PD-1 Therapy
    Lin, Jingwei
    Cai, Yingxin
    Ma, Yuxiang
    Pan, Jinyou
    Wang, Zuomin
    Zhang, Jianpeng
    Liu, Yangzhou
    Zhao, Zhigang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [35] Effect of anti-PD-1 and anti-Id-1 combo on tumor response and survival in lung cancer
    Baraibar, Iosune
    Roman, Marta
    Lopez, Ines
    Ajona, Daniel
    Calvo, Alfonso
    Guruceaga, Elisabeth
    Corral, Jesus
    Lasarte, Juan Jose
    Vicent, Silvestre
    Gil-Bazo, Ignacio
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [36] EFFECT OF ANTI-PD-1 THERAPY COMBINATION ON TEMOZOLOMIDE IN MOUSE GLIOBLASTOMA
    Park, Junseong
    Kim, Chang Gon
    Shim, Jin-Kyong
    Lee, Jae Eun
    Chang, Jong Hee
    Shin, Eui-Cheol
    Kang, Seok-Gu
    NEURO-ONCOLOGY, 2017, 19 : 116 - 116
  • [37] Prognostic impact of thyroid dysfunctions on progression-free survival in patients with metastatic melanoma treated with anti-PD-1 antibodies
    Frelau, Alexandra
    Jali, Eva
    Campillo-Gimenez, Boris
    Pracht, Marc
    Porneuf, Marc
    Dinulescu, Monica
    Edeline, Julien
    Boussemart, Lise
    Lesimple, Thierry
    MELANOMA RESEARCH, 2021, 31 (03) : 208 - 217
  • [38] S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies
    Wagner, Nikolaus B.
    Forschner, Andrea
    Leiter, Ulrike
    Garbe, Claus
    Eigentler, Thomas K.
    BRITISH JOURNAL OF CANCER, 2018, 119 (03) : 339 - 346
  • [39] S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies
    Nikolaus B Wagner
    Andrea Forschner
    Ulrike Leiter
    Claus Garbe
    Thomas K Eigentler
    British Journal of Cancer, 2018, 119 : 339 - 346
  • [40] Differences in treatment effect size between progression-free survival and overall survival in anti-PD-1/PD-L1 inhibitors-based trials in advanced NSCLC: a systematic review and meta-analysis
    Zhou, Zhirui
    Ren, Shengxiang
    Chen, Lingxiao
    Zhou, Caicun
    Jiang, Tao
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (06) : 2562 - +
12345